---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039650"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T13:58:02.323551+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix UroShield products now on NHS Drug Tariff; stocking order received

## Summary
- UroShield actuators eligible for full NHS reimbursement effective Nov 1, 2023.
- Received stocking order from UK distributor Peak Medical Limited; products shipped.
- Clinicians can prescribe via Drug Tariff or NHS procurement contract; patients no longer pay.
- CEO states increased demand since Nov 1; production ramped to meet expected growth.
- Partner Peak Medical will educate healthcare providers and accept orders.

## SEC filing metadata
- accession: 0001493152-23-039650
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315223039650/0001493152-23-039650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315223039650/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039650
- JSON: https://secwatch.observer/filing/0001493152-23-039650.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.